Dr Paolo A Muraro

Publications


Journals

  • Saccardi R; Freedman M; Sormani MP; Atkins H; Farge D; Griffith L; Kraft G; Mancardi G; et alNash R; Pasquini M; Martin R; Muraro P. (1 Mar 2012). A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Multiple Sclerosis. DOI.
  • Atkins HL; Muraro PA; van Laar JM; Pavletic SZ. (Jan 2012). Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?. Biol Blood Marrow Transplant. 18:S177-S183. DOI.
  • Scalfari A; Neuhaus A; Daumer M; Ebers GC; Muraro PA. (27 Sep 2011). Age and disability accumulation in multiple sclerosis. Neurology. 77:1246-1252. DOI.
  • Nicholas R; Giannetti P; Alsanousi A; Friede T; Muraro PA. (2011). Development of oral immunomodulatory agents in the management of multiple sclerosis. Drug Des Devel Ther. 5:255-274. DOI.
  • Scalfari A; Nicholas R; Malik O; Muraro P. Escalating Immunotherapies for highly active Multiple Sclerosis: reviewing the evidences. CML-Multiple Sclerosis.
  • Muraro PA; Abrahamsson SV. (1 Nov 2010). Resetting autoimmunity in the nervous system: The role of hematopoietic stem cell transplantation. CURRENT OPINION IN INVESTIGATIONAL DRUGS. 11:1265-1275. Author weblink.
  • Pasquini MC; Griffith LM; Arnold DL; Atkins HL; Bowen JD; Chen JT; Freedman MS; Kraft GH; et alMancardi GL; Martin R; Muraro PA; Nash RA; Racke MK; Storek J; Saccardi R. (1 Aug 2010). Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: Collaboration of the CIBMTR and EBMT to Facilitate International Clinical Studies. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 16:1076-1083. DOI.
  • Kiferle L; Politis M; Muraro PA; Piccini P. (Feb 2011). Positron emission tomography imaging in multiple sclerosis-current status and future applications. Eur J Neurol. 18:226-231. DOI.
  • Tappenden P; Saccardi R; Confavreux C; Sharrack B; Muraro PA; Mancardi GL; Kozak T; Farge-Bancel D; et alMadan J; Rafia R; Akehurst R; Snowden J. (1 Jun 2010). Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis. BONE MARROW TRANSPLANTATION. 45:1014-1021. DOI.
  • Scalfari A; Neuhaus A; Degenhardt A; Rice GP; Muraro PA; Daumer M; Ebers GC. (Jul 2010). The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain. 133:1914-1929. DOI.
  • Forsthuber TG; Muraro P. (1 May 2009). Is there a place for 'immuno' in the immunotherapy of multiple sclerosis?. IMMUNOTHERAPY. 1:329-331. DOI.
  • Dubinsky AN; Burt RK; Martin R; Muraro PA. (Feb 2010). T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft. Bone Marrow Transplant. 45:325-331. DOI.
  • Muraro PA; Uccelli A. (2010). Immuno-therapeutic potential of haematopoietic and mesenchymal stem cell transplantation in MS. Results Probl Cell Differ. 51:237-257. DOI.
  • Burt RK; Loh Y; Cohen B; Stefosky D; Balabanov R; Katsamakis G; Oyama Y; Russell EJ; et alStern J; Muraro P; Rose J; Testori A; Bucha J; Jovanovic B; Milanetti F; Storek J; Voltarelli JC; Burns WH. (1 Mar 2009). Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. LANCET NEUROLOGY. 8:244-253. Author weblink DOI.
  • Abrahamsson S; Muraro PA. (Dec 2008). Immune re-education following autologous hematopoietic stem cell transplantation. Autoimmunity. 41:577-584. DOI.
  • Kawamura K; Yao K; Shukaliak-Quandt JA; Huh J; Baig M; Quigley L; Ito N; Necker A; et alMcFarland HF; Muraro PA; Martin R; Ito K. (15 Oct 2008). Different development of myelin basic protein agonist- and antagonist-specific human TCR transgenic T cells in the thymus and periphery. J Immunol. 181:5462-5472.
  • Nash RA; Stuve O; Bowen JD; Frohman EM; Griffith LM; Hutton GJ; Kraft GH; Popat U; et alRacke MK; Muraro PA. (1 Feb 2008). Autologous HSCT for advanced MS: Is the glass half-empty or really half-full. BRAIN. 131. Author weblink DOI.
  • Muraro PA; Bielekova B. (Oct 2007). Emerging therapies for multiple sclerosis. Neurotherapeutics. 4:676-692. DOI.
  • Cassiani-Ingoni R; Muraro PA; Magnus T; Reichert-Scrivner S; Schmidt J; Huh J; Quandt JA; Bratincsak A; et alShahar T; Eusebi F; Sherman LS; Mattson MP; Martin R; Rao MS. (1 Jul 2007). Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 66:637-649. Author weblink DOI.
  • Packer AN; Muraro PA. (Mar 2007). Optimized clonotypic analysis of T-cell receptor repertoire in immune reconstitution. Exp Hematol. 35:516-521. DOI.
  • Openshaw H; Atkins HL; Chen JT; de Bittencourt PR; Griffith LM; Kerr DA; Khoury SA; Muraro PA; et alNash RA; Saccardi R. (Dec 2006). Multiple sclerosis conference synopsis and discussion: cellular therapy for treatment of autoimmune diseases (October 2005). Mult Scler. 12:824-825.
  • Muraro PA; Nikolov NP; Butman JA; Abati A; Gea-Banacloche J; Gress R; Lipsky P; Illei G; et alPavletic S. (Jun 2006). Granulocytic invasion of the central nervous system after hematopoietic stem cell transplantation for systemic lupus erythematosus. Haematologica. 91:ECR21.
  • Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R. (Jun 2006). Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain. 129:1493-1506. DOI.
  • Muraro PA; Cassiani-Ingoni R; Chung K; Packer AN; Sospedra M; Martin R. (Feb 2006). Clonotypic analysis of cerebrospinal fluid T cells during disease exacerbation and remission in a patient with multiple sclerosis. J Neuroimmunol. 171:177-183. DOI.
  • Sospedra M; Muraro PA; Stefanová I; Zhao Y; Chung K; Li Y; Giulianotti M; Simon R; et alMariuzza R; Pinilla C; Martin R. (1 Feb 2006). Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype. J Immunol. 176:1951-1961.
  • Muraro PA; Douek DC. (Feb 2006). Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol. 27:61-67. DOI.
  • Gupta S; Solomon JM; Tasciyan TA; Cao MM; Stone RD; Ostuni JL; Ohayon JM; Muraro PA; et alFrank JA; Richert ND; McFarland HF; Bagnato F. (Dec 2005). Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis. Mult Scler. 11:658-668.
  • Sospedra M; Zhao Y; zur Hausen H; Muraro PA; Hamashin C; de Villiers E-M; Pinilla C; Martin R. (1 Dec 2005). Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLOS PATHOGENS. 1:335-348. Author weblink DOI.
  • Griffith LM; Pavletic SZ; Tyndall A; Bredeson CN; Bowen JD; Childs RW; Gratwohl A; van Laar JM; et alMayes MD; Martin R; McSweeney PA; Muraro PA; Openshaw H; Saccardi R; Sandmaier BM; Forman SJ; Nash RA; Workshop participants. (Nov 2005). Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005. Biol Blood Marrow Transplant. 11:862-870. DOI.
  • Burt RK; Cohen B; Rose J; Petersen F; Oyama Y; Stefoski D; Katsamakis G; Carrier E; et alKozak T; Muraro PA; Martin R; Hintzen R; Slavin S; Karussis D; Haggiag S; Voltarelli JC; Ellison GW; Jovanovic B; Popat U; McGuirk J; Statkute L; Verda L; Haas J; Arnold R. (1 Jun 2005). Hematopoietic stem cell transplantation for multiple sclerosis. ARCHIVES OF NEUROLOGY. 62:860-864. Author weblink DOI.
  • Muraro PA; Douek DC; Packer A; Chung K; Guenaga FJ; Cassiani-Ingoni R; Campbell C; Memon S; et alNagle JW; Hakim FT; Gress RE; McFarland HF; Burt RK; Martin R. (7 Mar 2005). Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med. 201:805-816. DOI.
  • Quandt JA; Baig M; Yao K; Kawamura K; Huh JB; Ludwin SK; Bian HJ; Bryant M; et alQuigley L; Nagy ZA; McFarland HE; Muraro PA; Martin R; Ito K. (19 Jul 2004). Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice. JOURNAL OF EXPERIMENTAL MEDICINE. 200:223-234. Author weblink DOI.
  • Huh J; Yao K; Quigley L; Ludwin SK; McFarland HF; Muraro PA; Martin R; Ito K. (Jun 2004). Limited repertoire of HLA-DRB1*0401-restricted MBP111-129-specific T cells in HLA-DRB1*0401 Tg mice and their pathogenic potential. J Neuroimmunol. 151:94-102. DOI.
  • Muraro PA; Liberati L; Bonanni L; Pantalone A; Caporale CM; Iarlori C; De Luca G; Farina D; et alLugaresi A; Gambi D. (May 2004). Decreased integrin gene expression in patients with MS responding to interferon-beta treatment. J Neuroimmunol. 150:123-131. DOI.
  • Muraro PA; Cassiani-Ingoni R; Martin R. (2004). Using stem cells in multiple sclerosis therapies. Cytotherapy. 6:615-620. DOI.
  • Muraro PA; Martin R. (Aug 2003). Immunological questions on hematopoietic stem cell transplantation for multiple sclerosis. BONE MARROW TRANSPL. 32:S41-S44.
  • Muraro PA; Cassiani Ingoni R; Martin R. (Jun 2003). Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges. Curr Opin Neurol. 16:299-305. DOI.
  • Muraro PA; Wandinger KP; Bielekova B; Gran B; Marques A; Utz U; McFarland HF; Jacobson S; et alMartin R. (Jan 2003). Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders. Brain. 126:20-31.
  • Muraro PA; Kalbus M; Afshar G; McFarland HF; Martin R. (Sep 2002). T cell response to 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) in multiple sclerosis patients. J Neuroimmunol. 130:233-242.
  • Muraro PA; Bonanni L; Mazzanti B; Pantalone A; Traggiai E; Massacesi L; Vergelli M; Gambi D. (Jun 2002). Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS. J Neuroimmunol. 127:149-159.
  • Lugaresi, A; Caporale, C; Farina, D; Marzoli, F; Bonanni, L; Muraro, P A; De Luca, G; Iarlori, C; et alGambi, D. (2001). Low-dose oral methotrexate treatment in chronic progressive multiple sclerosis. Neurological Sciences. 22:209-210.
  • Muraro PA; Jacobsen M; Necker A; Nagle JW; Gaber R; Sommer N; Oertel WH; Martin R; et alHemmer B. (1 Dec 2000). Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysis. J Immunol Methods. 246:131-143.
  • Muraro PA; Leist T; Bielekova B; McFarland HF. (1 Nov 2000). VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis. J Neuroimmunol. 111:186-194.
  • Muraro PA; Pette M; Bielekova B; McFarland HF; Martin R. (15 May 2000). Human autoreactive CD4+ T cells from naive CD45RA+ and memory CD45RO+ subsets differ with respect to epitope specificity and functional antigen avidity. J Immunol. 164:5474-5481.
  • Bielekova B; Muraro PA; Golestaneh L; Pascal J; McFarland HF; Martin R. (Dec 1999). Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7. J Neuroimmunol. 100:115-123.
  • Pette M; Muraro PA; Pette DF; Dinter H; McFarland HF; Martin R. (3 Aug 1999). Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones. J Neuroimmunol. 98:147-156.
  • Muraro PA; Martin R; Lassmann H; Gambi D. (3 May 1999). Plaques, T cells and beyond: report on an international meeting on the immunological basis of multiple sclerosis held at the University of Chieti, Italy. JOURNAL OF NEUROIMMUNOLOGY. 96:251-254. Author weblink DOI.
  • Afshar G; Muraro PA; McFarland HF; Martin R. (1 Apr 1998). Lack of over-expression of T cell receptor Vbeta5.2 in myelin basic protein-specific T cell lines derived from HLA-DR2 positive multiple sclerosis patients and controls. J Neuroimmunol. 84:7-13.
  • Pette M; Pette DF; Muraro PA; Farnon E; Martin R; McFarland HF. (Aug 1997). Interferon-beta interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes. Neurology. 49:385-392.
  • Muraro PA; Vergelli M; Kalbus M; Banks DE; Nagle JW; Tranquill LR; Nepom GT; Biddison WE; et alMcFarland HF; Martin R. (15 Jul 1997). Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. J Clin Invest. 100:339-349. DOI.
  • Pette M; Pette DF; Muraro PA; Martin R; McFarland HF. (Jun 1997). In vitro modulation of human, autoreactive MBP-specific CD4 + T-cell clones by cyclosporin A. J Neuroimmunol. 76:91-99.
  • Rosener M; Muraro PA; Riethmuller A; Kalbus M; Sappler G; Thompson RJ; Lichtenfels R; Sommer N; et alMcFarland HF; Martin R. (1 May 1997). 2',3'-cyclic nucleotide 3'-phosphodiesterase: A novel candidate autoantigen in demyelinating diseases. JOURNAL OF NEUROIMMUNOLOGY. 75:28-34. Author weblink DOI.
  • Vergelli M; Hemmer B; Muraro PA; Tranquill L; Biddison WE; Sarin A; McFarland HF; Martin R. (15 Mar 1997). Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis. J Immunol. 158:2756-2761.

Chapters in books

  • Muraro P; Van Laar J; Illei G; Pavletic S. Hematopoietic stem cell transplantation for autoimmune disorders. In Hematopoietic Stem Cell Transplantation in Clinical Practice. 197-210. Barrett AJ (ed); Treleaven J (ed). Churchill Livingstone/Elsevier Science, Edinburgh (2008).
  • Muraro, P A; McFarland, H F; Martin, R. Immunological Aspects of Multiple Sclerosis with Emphasis on the Potential Use of Autologous Hemopoietic Stem Cell Transplantation. In Stem Cell Therapy for Autoimmune Diseas. 277-283. Burt R (ed); Marmont A (ed). Landes Bioscience, Georgetown, TX (2003). Author weblink.
  • Muraro, P A; Bielekova, B. The naïve and memory MBP-reactive CD4+ T cell repertoire. In Advances in the Immunopathogenesis of Multiple Sclerosis. 11-19. Gambi D (ed); Muraro PA (ed); Lugaresi A (ed). Springer-Verlag, Milan (1999). Author weblink.
  • Frontoni, M; Muraro, PA; Argentino, C; Cavalletti, C; Fieschi, C. Cardioneurology: State of the Art and Perspective. In Neurocardiology. 1-6. Nappi (ed); G (ed); Richichi (ed); I (ed); Micieli M (ed); Friedman M (ed). Smith-Gordon, London (1993).
  • Muraro, P A. Immune regeneration through hematopoietic stem cell transplantation to restore tolerance in autoimmune disease. In Immunotherapy for Autoimmune Disease. Zhang J (ed). Springer Life Sciences, New York.

Conferences

  • Nash RA; Hutton GJ; Racke MK; Popat UR; Devine SM; Griffith LM; Muraro PA; Openshaw H; et alSayre PH; Stuve O; Arnold DL; Wruck L; Wundes A; Kraft GH; Bowen JD. Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI). 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, 10 Dec 2011 - 13 Dec 2011. 118:1326-1327. AMER SOC HEMATOLOGY (18 Nov 2011). Author weblink.
  • Scalfari A; Giannetti P; Neuhaus A; Daumer M; Muraro PA; Ebers G. Frequent early relapses and long-term disease evolution in multiple sclerosis. 21st Meeting of the European-Neurological-Society, 28 May 2011 - 31 May 2011. 258:95-95. SPRINGER HEIDELBERG (1 May 2011).
  • Ebers G; Neuhaus A; Muraro P; Daumer M; Harner N; Degenhardt A; Rice GP; Scalfari A. THE NATURAL HISTORY OF MULTIPLE SCLEROSIS, A GEOGRAPHICALLY BASED STUDY. 10: RELAPSES AND LONG-TERM DISABILITY. Annual Meeting of the Association-of-British-Neurologists, 11 May 2010 - 14 May 2010. 81:E31-E31. B M J PUBLISHING GROUP (1 Nov 2010). Author weblink DOI.
  • Nicholas R; D'Arcy C; Muraro P; McGuigan C; Malik O; Giannetti P; O'Driscoll S. USING NATALIZUMAB IN HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS IN THE UK. Annual Meeting of the Association-of-British-Neurologists, 11 May 2010 - 14 May 2010. 81:E53-E53. B M J PUBLISHING GROUP (1 Nov 2010). Author weblink DOI.
  • Mattoscio M; Nicholas R; Malik O; Mc Guigan C; Dazzi F; Muraro PA. Functional relevance of haematopoietic stem cell mobilization following therapeutic alpha 4-integrin blockade in multiple sclerosis: preliminary data. 20th Meeting of the European-Neurological-Society, 19 Jun 2010 - 23 Jun 2010. 257:S221-S221. SPRINGER HEIDELBERG (1 Jun 2010).
  • Scalfari A; Neuhaus A; Daumer M; Ebers G; Muraro PA. The effect of age on disability development in multiple sclerosis. 20th Meeting of the European-Neurological-Society, 19 Jun 2010 - 23 Jun 2010. 257:S74-S74. SPRINGER HEIDELBERG (1 Jun 2010).
  • Illei GG; Nikolov NP; Hakim F; Leitman S; Yarboro C; Balow J; Austin H; Gea-Banacloche J; et alMuraro P; Oh U; Odom J; Hardwick D; Muraro P; Sportes C; Lipsky P; Gress R; Pavletic S. LONG-TERM OUTCOMES OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTO HSCT) USING LYMPHOABLATIVE CONDITIONING REGIMEN IN SYSTEMIC LUPUS ERYTHEMATOSUS - THE NIH EXPERIENCE. Conference on Haematopoietic Stem Cell Transplantation for Severe Autoimmune Diseases, 19 Nov 2009 - 20 Nov 2009. 45:S6-S6. NATURE PUBLISHING GROUP (1 Feb 2010). Author weblink.
  • Abrahamsson S; Dubinsky A; Angelini D; Oh U; Battistini L; Martin R; Burt R; Muraro PA. AUTOLOGOUS NON-MYELOABLATIVE HAEMATOPOIETIC STEM CELL TRANSPLANTATION FAVOURABLY MODIFIES THE BALANCE OF REGULATORY AND PRO-INFLAMMATORY T CELL SUBSETS. Conference on Haematopoietic Stem Cell Transplantation for Severe Autoimmune Diseases, 19 Nov 2009 - 20 Nov 2009. 45:S18-S18. NATURE PUBLISHING GROUP (1 Feb 2010).
  • Freedman M; Amato MP; Atkins H; Carreras E; Fassas A; Griffith LM; Kerr D; Martin R; et alMassacesi L; Muraro P; Nash R; Pasquini M; Saccardi R; Sormani MP; Mancardi G. Panel Session Report: Multiple Sclerosis. Conference on Haematopoietic Stem Cell Transplantation for Severe Autoimmune Diseases, 19 Nov 2009 - 20 Nov 2009. 45:S8-S10. NATURE PUBLISHING GROUP (1 Feb 2010).
  • Muraro PA. Restoring self tolerance: lessons from the clinic. Conference on Haematopoietic Stem Cell Transplantation for Severe Autoimmune Diseases, 19 Nov 2009 - 20 Nov 2009. 45:S2-S2. NATURE PUBLISHING GROUP (1 Feb 2010).
  • Muraro P. Resetting autoimmunity in the nervous system; the role of bone marrow transplantation. 13th Congress of the European-Federation-of-Neurological-Societies, 12 Sep 2009 - 15 Sep 2009. 16:8-8. WILEY-BLACKWELL PUBLISHING, INC (1 Oct 2009). Author weblink.
  • Mancardi GL; Gualandi F; Saccardi R; Muraro P; Van Lint MT; Sormani MP; Capello E; Leonardi A; et alBonanni I; Roccatagliata L; Pardini M; Bonzano L; Uccelli A; Vuolo L. A prospective clinical and MRI study of a low-intensity conditioning regimen followed by autologous haematopoietic stem cell transplantation in severe multiple sclerosis. 25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 9 Sep 2009 - 12 Sep 2009. 15:S253-S253. SAGE PUBLICATIONS LTD (1 Sep 2009). Author weblink.
  • Neuhaus A; Strobl R; Daumer M; Scalfari A; Muraro P; Ebers G. Analysis of long-term clinical outcome in multiple sclerosis - a longitudinal approach. 25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 9 Sep 2009 - 12 Sep 2009. 15:S163-S163. SAGE PUBLICATIONS LTD (1 Sep 2009). Author weblink.
  • Scalfari A; Neuhaus A; Harner N; Seemueller S; Nicholas R; Ebers G; Daumer M; Muraro PA. The London Ontario Database: a descriptive analysis of 25 years of follow-up. 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, 17 Sep 2008 - 20 Sep 2008. 14:S198-S199. SAGE PUBLICATIONS LTD (1 Sep 2008). Author weblink.
  • Abrahamsson S; Packer A; Oh U; Burt RK; Muraro PA. Dose matters: different immunological effects following a reduced- or high-intensity autologous hematopoietic stem cell transplantation regimen in patients with multiple sclerosis. 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, 17 Sep 2008 - 20 Sep 2008. 14:S23-S23. SAGE PUBLICATIONS LTD (1 Sep 2008). Author weblink.
  • Muraro PA; Saccardi R; Mancardi GL. Autologous haematopoietic stem cell transplantation in severe multiple sclerosis: The Italian experience. Annual Meeting of the Association-of-British-Neurologists, 14 Nov 2007 - 16 Nov 2007. 79:339-339. B M J PUBLISHING GROUP (1 Mar 2008). Author weblink.
  • Abrahamsson SV; Packer AN; Oh U; Burt RK; Martin R; Muraro PA. Increased frequency of immuno-regulatory T-cells in patients with multiple sclerosis after haematopoietic stem cell transplantation. 23rd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/12th Annual Conference of Rehabilitation in MS, 11 Oct 2007 - 14 Oct 2007. 13:S247-S247. SAGE PUBLICATIONS LTD (1 Oct 2007). Author weblink.
  • Nikolov NP; Illei GG; Yarboro C; Hakim F; Leitman S; Read E; Khuu H; Gramrner A; et alFischer R; Balow J; Austin H; Gea-Banacloche J; Muraro P; Babb R; Krumlauf M; Sportes C; Lipsky P; Gress R; Pavletic S. Effective immune depletion following novel lymphoablative regimen for autologous hematopoietic stem cell transplantation (AutoHSCT) in systemic lupus erythematosus (SLE). 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. 54:S790-S790. (Sep 2006).
  • Sospedra M; Zhao Y; zur Hansen H; Muraro P; Hamashin C; de Viliers E; Pinilla C; Martin R. Arginine-enriched protein domains from the non-pathogenic torque teno virus and other common viruses trigger autoreactive T cells in multiple sclerosis. 21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS, 28 Sep 2005 - 1 Oct 2005. 11:S135-S135. HODDER ARNOLD, HODDER HEADLINE PLC (1 Sep 2005). Author weblink.
  • Sospedra M; Zhao Y; Muraro P; Jacobson S; Pinilla C; Martin R. Identification of putative trigger agents in multiple sclerosis using an unbiased approach. 7th International Congress of the International-Society-of-Neuroimmunology, 28 Sep 2004 - 2 Oct 2004. 154:182-182. ELSEVIER SCIENCE BV (1 Sep 2004). Author weblink.
  • Muraro PA; Chung K; Douek D; McFarland HF; Burt RK; Martin R. Immunological mechanisms of autologous hematopoietic stem cell transplantation as a therapy for multiple sclerosis. 7th International Congress of the International-Society-of-Neuroimmunology, 28 Sep 2004 - 2 Oct 2004. 154:210-210. ELSEVIER SCIENCE BV (1 Sep 2004). Author weblink.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook